기본 정보
- 표준 SMILES
c1ccc(N2CCNCC2)cc1- InChIKey
YZTJYBJCZXZGCT-UHFFFAOYSA-N- 분자식
- C10H14N2
- 평균 분자량
- 162.23 g/mol
- 단동위원소 질량
- 162.11569846
이름 및 식별자
- 우선 이름
- 1-Phenylpiperazine
- IUPAC
- 1-phenylpiperazine
- 현지명
- 1-페닐피페라진이염산염
- 영어명
- 1-Phenylpiperazine dihydrochloride
- 분자식
- C10H16Cl2N2
- 분자량
- 235.15
이름 및 동의어
이름 더 보기
데이터베이스 식별자
- CAS
4004-95-9、92-54-6- PubChem CID
- 7096
- DTXSID
DTXSID8057855- ChEMBL
CHEMBL9434- UNII
- J9225CBI7D
- EC Number
- 202-165-6
- Nikkaji
- J35.451A
물성
구조 계산 물성
- XLogP
- 1.1
- 극성 표면적
- 15.3 Ų
- 수소 결합 공여자 수
- 1
- 수소 결합 수용자 수
- 2
- 회전 가능 결합 수
- 1
- 무거운 원자 수
- 12
- 형식 전하
- 0
- 복잡도
- 124
실험 및 물리화학적 성질
물리화학적 성질
- 녹는점
- 221 · 221-223°C
- 저장 조건
- Hygroscopic, Refrigerator, Under Inert Atmosphere
- 용해도
- DMSO(약간 용해됨), 메탄올(약간 용해됨), 물(약간 용해됨)
- 물리적 상태
- 고체
- 색상
- 흰색에서 황백색까지
- 안정성
- 흡습성
화학적 성질
White Solid
안전 및 규제
GHS 분류
GHS Classification
Danger
H301 (96.9%): Toxic if swallowed [Danger Acute toxicity, oral];H310 (36.9%): Fatal in contact with skin [Danger Acute toxicity, dermal];H311 (61.5%): Toxic in contact with skin [Danger Acute toxicity, dermal];H314 (98.5%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]
P260, P262, P264, P270, P280, P301+P316, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P321, P330, P361+P364, P363, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 65 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
유해성 정보
Regulatory Information
Status: Active Update: 09-04-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/21606
Piperazine, 1-phenyl-, dihydrochloride: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Phenylpiperazine: Does not have an individual approval but may be used under an appropriate group standard
규제 정보
Regulatory Information
Status: Active Update: 09-04-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/21606
Piperazine, 1-phenyl-, dihydrochloride: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Phenylpiperazine: Does not have an individual approval but may be used under an appropriate group standard
안전 데이터
- 신호 어
- Warning
- 유해·위험 문구
- 암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드 H315
화학 및 산업
약리 정보
MeSH Pharmacological Classification
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).
용도 및 제조
응용 분야
용도1-Phenylpiperazine was tested for its activity as a topical glaucoma agent.
공급사7 곳
관련 반응
연결된 노트
불러오는 중…